A Phase I study of acivicin in refractory pediatric solid tumors
- 1 September 1995
- journal article
- clinical trial
- Published by Springer Nature in Investigational New Drugs
- Vol. 13 (3) , 211-215
- https://doi.org/10.1007/bf00873802
Abstract
Forty-two patients with progressive solid tumors and brain tumors were entered in this Phase I study of the glutamine antagonist acivicin given intravenously over thirty minutes daily for five days. The major toxicities encountered were myelosuppression and central nervous system toxicity (nightmares and somnolence). The maximum tolerated dosage on this schedule was 26 mg/M2 daily for five days. Six patients including three patients with brain tumor had stable disease.Keywords
This publication has 17 references indexed in Scilit:
- Glutathione and glutathione conjugate efflux from cultured liver cellsCell Biology and Toxicology, 1991
- Action and Sequence Dependent Interaction of Acivicin and 6-Thioguanine in Human Derived Malignant T-All and Calla+ Cell LinesPublished by Springer Nature ,1991
- Phase I Study of Acivicin and Cisplatin in Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1990
- Effects of the combination of acivicin and cis-diammine-dichloroplatinum(II) on thymidylate synthesis of A549 lung cancer cellsBiochemical and Biophysical Research Communications, 1989
- Effect of inhibition of γ-glutamyltranspeptidase by AT-125 (Acivicin) on glutathione and cysteine levels in rat brain and plasmaInvestigational New Drugs, 1985
- INFLUENCE OF GLUTAMINE ON THE GROWTH OF HUMAN GLIOMA AND MEDULLOBLASTOMA IN CULTURE1985
- Phase II trial of acivicin in advanced metastatic breast cancer.1983
- Phase I study of acivicin in patients with advanced cancer.1983
- PHASE-I TRIAL AND PHARMACOKINETICS OF ACIVICIN ADMINISTERED BY 72-HOUR INFUSION1983
- The inhibition of γ-glutamyl transpeptidase and glutathione metabolism of isolated rat kidney cells by L-(αS, 5S)-α-amino-3-chloro-4, 5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501)Biochemical and Biophysical Research Communications, 1980